Karolinska Seeks New Investments In Portfolio Shakeup Aftermath
This article was originally published in Clinica
Following the recent re-alignment of its portfolio, Sweden-based technology incubator and investor Karolinska Development is now looking to put more money into additional medtech companies that are close to commercialization or already generating early revenue.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.